Clotting Disorders

A collection of features and news articles published in ASH Clinical News related to clotting disorders.

Xarelto Manufacturers Settle Lawsuits Over Bleeding Risks

Johnson & Johnson and Bayer, the manufacturers of rivaroxaban (sold as Xarelto), have agreed to pay $775 million to settle thousands of lawsuits over...

FDA Approves Caplacizumab-yhdp for Acquired TTP

Caplacizumab-yhdp, a bivalent anti–von Willebrand factor nanobody, was approved for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP), in combination with...

Higher Doses of Tofacitinib Increase Risk of Pulmonary Embolism and Death

The U.S. Food and Drug Administration (FDA) has issued a Safety Announcement after a safety clinical trial of the immunology drug tofacitinib found an...

Planes, Trains, and VTEs

Simple recommendations can help mitigate risk for travel-related blood clots In November 2011, hematologist Suely Rezende, MD, PhD, deplaned from a flight from Lisbon to...

Roche Will Donate Hemophilia A Drug to Developing Countries

Roche will donate its new hemophilia A drug emicizumab-kxwh to the World Hemophilia Federation (WHF) Humanitarian Aid Program. Roche joins other companies – including...

SHARE